Vanguard Fiduciary Trust
IGC icon

Vanguard Fiduciary Trust’s IGC Pharma IGC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
419,413
+3,525
+0.8% +$1.04K ﹤0.01% 3713
2026
Q1 		$109K Buy
+415,888
New +$115K ﹤0.01% 3693

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Fiduciary Trust's IGC Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its IGC Pharma (IGC) stake by 0.85% in Q2 2026, buying an estimated $1.04K and bringing the position to 419,413 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

Vanguard Fiduciary Trust first reported a position in IGC in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Vanguard Fiduciary Trust held 419,413 shares of IGC Pharma worth $114K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 3,525 IGC Pharma shares in Q2 2026, an estimated $1.04K.
  • IGC Pharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3713 holding.
  • Vanguard Fiduciary Trust first reported a position in IGC Pharma in Q1 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.